Home » View latest Dutasteride Tenders from India

View latest Dutasteride Tenders from India

TendersOnTime provides latest updates on Indian Dutasteride Tenders from various state and central government tendering authorities. The information on Dutasteride online tenders and turnkey projects from India is collected from various sources viz: e procurement tenders list, newspapers and tender bulletin etc.

Country: India

Tab. Silodosin 4Mg + Dutasteride 0.5Mg.

TOT Ref No.: 100051758

Deadline: 26 Apr 2024

Country: India

Tab Tamsulosine 0.4Mg + Dutasteride 0.5Mg

TOT Ref No.: 100061546

Deadline: 20 Apr 2024

Country: India

Tab Dutasteride 0.5 Mg+ Tamsulosin 0.4 Mg

TOT Ref No.: 100109562

Deadline: 20 Apr 2024

Country: India

Tab. Silodosin with Dutasteride (Each Tab/Cap Contains Silodosin 8 Mg & Dutasteride 0.5 Mg. Packed

TOT Ref No.: 100003030

Deadline: 24 Apr 2024

Country: India

Dutasteride 0.5Mg with Tamsulosin 0.4Mg Tab/Cap Ph_No.

TOT Ref No.: 100161056

Deadline: 24 Apr 2024

Country: India

Supply Of Dutasteride Tablets 0.5 mg tab Qty 800 At Rishikesh

TOT Ref No.: 99578531

Deadline: 29 Apr 2024

Country: India

Supply Of Tamsulosin + Dutasteride Tablets 0.4 mg+0.5 mg tab Qty:-500 At Rishikesh

TOT Ref No.: 99581373

Deadline: 29 Apr 2024

Country: India

(2024-25 Ami Code-28U 029) Silodosin 8Mg and Dutasteride 0.5Mg

TOT Ref No.: 100049955

Deadline: 01 May 2024

Country: India

Tamsulin 0.4 Mg Dutasteride 5 Mg Tab, Qty: 1800 No, (BOQ Item #9)

TOT Ref No.: 100148254

Deadline: 09 May 2024

Country: India

Dutasteride 0Point5 Mg Plus Tamsulosin 0Point4mg Tab, Qty: 2130 No, (BOQ Item #11)

TOT Ref No.: 99465048

Deadline: 20 Apr 2024

Country: {{rowDetails.Country_Name}}

TOT Ref No.: {{rowDetails.ID}}

Deadline: {{rowDetails.Bid_Deadline_1}}

Deadline: {{rowDetails.Bid_Deadline_1}}

No data Found!! Please search again

Browse Tenders

Browse Tenders from below Sections

Call Action

Get A Callback Within 24 Hours

Fill form below to get callback from Tender Experts.

Click button to send your details.